Prognostic Value of Circulating Tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL): Systematic Review and Meta-Analysis.
Circulating tumor DNA shows promise as a prognostic marker in lymphoma, potentially helping doctors identify higher-risk patients earlier.
This PubMed record reports: 1007/s12288-025-02234-1. The finding is retained for rapid triage and requires downstream evidence review before clinical interpretation.
What the study was
- Study design
- Meta-analysis
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Why it surfaced
Retained because its meta-analysis evidence is relevant to Early cancer detection (liquid biopsy, ctDNA, cfDNA); scoring is conservative for the available metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.